Written and maintained by CASRAI Editorial Board
Last updated
Reverse logistics for medical devices is the movement of a device back from the customer toward the supplier or manufacturer, for return, repair, investigation or disposal. For a regulated device the physical return is only half the job: the manufacturer’s records decide what happened to the unit and what had to be reported. This page maps each stage of a return to the U.S. FDA record or report that can attach to it. This page describes products and general use; it is not medical advice.
Who uses this: buyers, procurement and supply staff, biomedical or clinical engineering staff, and quality or regulatory staff at suppliers and manufacturers.
What reverse logistics means for medical devices
Reverse logistics is the flow of goods in the opposite direction to a sale. For medical devices it covers returns of unused product, returns for repair or servicing, and returns tied to a complaint, a recall or a field action. The paperwork that opens a return, usually a return authorization or RMA number, is a purchasing document; see RMA meaning in lab and medical purchasing for that. Drug returns follow a separate pathway, covered in pharmaceutical returns.
The reason a device is coming back matters, because the FDA record requirements discussed below attach to complaints, servicing and corrections or removals, not to the act of shipping a box.
From return authorization to disposition: the stages
The stages below are an editorial framing of a typical return, not a regulatory list. Only the FDA hooks in the next section are drawn from the regulations.
- Return authorization. The supplier agrees to take the unit back and records the reason (unused, defective, repair, field action).
- Receipt and segregation. The returned unit is identified, using its device identifiers where it carries them, and kept apart from saleable stock. See medical inventory tracking for what to record per item (UDI, lot, expiry).
- Complaint or service record. If the return reports a problem, the manufacturer’s complaint and servicing records apply.
- Reportability check. The manufacturer decides whether the event triggers an adverse-event report or a correction or removal report.
- Disposition. The unit is repaired, scrapped or otherwise dealt with, and the outcome is recorded. Selling surplus or used equipment on is a separate topic: how to sell used medical equipment.
Records a returned device can trigger
| Stage | Record or report that can attach | What it must contain | Source |
|---|---|---|---|
| A customer reports a problem with a returned device | Complaint record (for complaints reportable under Part 803, complaints the manufacturer determines must be investigated, and complaints it investigated anyway) | Device name, date received, device identifiers, complainant name, address and phone number, nature and details of the complaint, any correction or corrective action, any reply to the complainant. If a similar complaint was already investigated, the file documents the justification for not investigating again. | 21 CFR 820.35(a) |
| The unit is serviced or repaired | Servicing record | At a minimum: device name, any UDI or UPC and other device identification, date of service, who serviced the device, the service performed, and any test and inspection data. | 21 CFR 820.35(b) |
| Any device or batch of devices handled | UDI recorded | The unique device identifier must be recorded for each medical device or batch of medical devices. | 21 CFR 820.35(c) |
| Returned unit suggests it may have caused or contributed to a death or serious injury, or malfunctioned in a way that could do so if it recurred | Manufacturer adverse-event report | Reported no later than 30 calendar days after the manufacturer receives or becomes aware of the information. | 21 CFR 803.50 |
| The manufacturer starts a correction or removal to reduce a risk to health | Correction and removal report | Written report within 10 working days of initiating the action: tracking number, contacts, device identification and marketing status, description of the event, corrective actions, injuries, number of devices affected, distribution and related communications. | 21 CFR 806.10 |
Source: eCFR, checked 2026-11-01 (full links in the Sources section). Part 820 is titled Quality Management System Regulation, and 820.35 (Control of records) is the current numbering.
Reporting clocks: adverse events versus corrections and removals
Adverse-event reports (30 days)
Under 21 CFR 803.50, a manufacturer must report no later than 30 calendar days after it receives or becomes aware of information, from any source, that reasonably suggests a marketed device may have caused or contributed to a death or serious injury, or has malfunctioned in a way that could cause such harm if it recurred. Part 803 also has separate subparts for user facilities (803.30 to 803.33) and importers (803.40 to 803.42) (see the Part 803 index linked in Sources).
Corrections and removals (10 working days)
Under 21 CFR 806.10, a manufacturer or importer reports in writing a correction or removal initiated to reduce a risk to health posed by the device, or to remedy a violation that may present such a risk, within 10 working days of initiating it. The clock starts when the action is initiated, not when a problem is first noticed. For the customer-facing side of a field action, see the medical device recall letter template.
What to ask a supplier to document
This checklist is derived only from the record fields above. It is a list of questions, not a statement of what any supplier must give you.
- Which identifiers (including the UDI) are recorded for each returned unit or batch?
- How does the supplier record a complaint raised with a return, and what fields does the record hold?
- When a returned unit is serviced, what is recorded: who serviced it, what was done, and what test and inspection data exist?
- Who decides whether a returned unit triggers an adverse-event report or a correction or removal report?
- How is the disposition of each unit recorded?
Background on the regulation itself is in the 21 CFR Part 820 guide.
Common mistakes
- Treating the RMA number as the record. It authorizes a shipment. The complaint and servicing records in 820.35 are separate.
- Mixing up the two clocks. 30 calendar days from becoming aware of the information (803.50) is not 10 working days from initiating an action (806.10).
- Returning units without identifiers. 820.35(c) requires the UDI to be recorded, so a unit that cannot be identified is hard to trace.
- Assuming a return is always a complaint. A return only creates a complaint record where a complaint is made; check how the supplier classifies it.
FAQ
What is reverse logistics in the medical device industry?
It is the return flow of devices from customers back to a supplier or manufacturer for return, repair, investigation or disposal. For regulated devices, it is tied to the manufacturer’s complaint, servicing and reporting records.
What is an RMA number?
A return merchandise authorization number is the reference a supplier issues to approve a return. It is covered in RMA meaning.
What is the medical supply returns process?
Typically: authorization, receipt and segregation, complaint or service record where relevant, a reportability check, and disposition. The stages are described above; the regulatory hooks are the 820.35, 803.50 and 806.10 records.
What is a medical equipment return authorization?
It is the same purchasing document applied to equipment. It does not itself satisfy any FDA record requirement.
Does every returned device have to be reported to FDA?
No. Reports are triggered by events described in 803.50 and 806.10, not by the return itself.
Sources
All checked 2026-11-01.
- 21 CFR 820.35, Control of records: https://www.ecfr.gov/current/title-21/part-820/section-820.35
- 21 CFR 806.10, Reports of corrections and removals: https://www.ecfr.gov/current/title-21/part-806/section-806.10
- 21 CFR 803.50, Manufacturer reporting requirements: https://www.ecfr.gov/current/title-21/part-803/section-803.50
- 21 CFR Part 803 index: https://www.law.cornell.edu/cfr/text/21/part-803
